Gut microbiota in Parkinson’s disease patients: hospital-based study

Abstract Background Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. There is accumulating evidence that link gut microbiota to symptomatology and pathophysiology of PD. The aim of this study was to describe the pattern of gut microbiota and its association with PD and...

Full description

Bibliographic Details
Main Authors: Eman M. Khedr, Anwar M. Ali, Enas Deaf, Hebatallah M. Hassan, Ahmed Alaa, Ayman Gamea
Format: Article
Language:English
Published: SpringerOpen 2021-11-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Online Access:https://doi.org/10.1186/s41983-021-00407-z
_version_ 1818934526939758592
author Eman M. Khedr
Anwar M. Ali
Enas Deaf
Hebatallah M. Hassan
Ahmed Alaa
Ayman Gamea
author_facet Eman M. Khedr
Anwar M. Ali
Enas Deaf
Hebatallah M. Hassan
Ahmed Alaa
Ayman Gamea
author_sort Eman M. Khedr
collection DOAJ
description Abstract Background Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. There is accumulating evidence that link gut microbiota to symptomatology and pathophysiology of PD. The aim of this study was to describe the pattern of gut microbiota and its association with PD and identify the effect of environmental factors on gut microbiota. This case–control study included 46 patients diagnosed as Parkinson’s disease (PD) and 31 healthy volunteers age and sex matched. Detailed history including age of onset, duration of disease, environmental risk factors, diet data, treatment, Unified Parkinson’s Disease Rating Scale (UPDRS), and gastrointestinal tract (GIT) domain of Non‐Motor Symptoms Scale (NMSS) were assessed. After extraction of bacterial DNA from the fecal samples, bacterial abundance was quantified by qPCR using 16S rRNA group-specific primers. Results Significant high abundance of Clostridium cluster IV, Akkermansia, Bifidobacterium, and lactic acid bacteria were found in the PD group compared with the control group (P < 0.001, 0.04, 0.02 and < 0.001, respectively), while Firmicutes were significantly less abundant in the PD group (P < 0.001) compared with the control group. The naive PD patients had significant abundance of Bifidobacterium, and lactic acid compared with control group. Interestingly, Akkermansia was more abundant in treated than untreated patients. There were significant associations between pesticide exposure and Bifidobacterium (P = 0.002), while no significant correlations between different gut microbiota and demographic, environment data, different rating scores or dominant type of PD. There was a significant negative correlation between the Bifidobacterium with the duration of illness (P = 0.012). Conclusion The present study highlighted a significant connection between PD and levels of certain types of gut microbiota, in support of a possible link between gut microbiota and a neurodegenerative cascade of PD.
first_indexed 2024-12-20T05:05:41Z
format Article
id doaj.art-3015efca1fe3486495ce07b83d474343
institution Directory Open Access Journal
issn 1687-8329
language English
last_indexed 2024-12-20T05:05:41Z
publishDate 2021-11-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
spelling doaj.art-3015efca1fe3486495ce07b83d4743432022-12-21T19:52:24ZengSpringerOpenThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery1687-83292021-11-015711910.1186/s41983-021-00407-zGut microbiota in Parkinson’s disease patients: hospital-based studyEman M. Khedr0Anwar M. Ali1Enas Deaf2Hebatallah M. Hassan3Ahmed Alaa4Ayman Gamea5Department of Neuropsychiatry, Assiut University Hospital, Faculty of MedicineDepartment of Neuropsychiatry, Assiut University Hospital, Faculty of MedicineDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut UniversityDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut UniversityDepartment of Neuropsychiatry, Assiut University Hospital, Faculty of MedicineDepartment of Neuropsychiatry, South Valley University HospitalAbstract Background Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. There is accumulating evidence that link gut microbiota to symptomatology and pathophysiology of PD. The aim of this study was to describe the pattern of gut microbiota and its association with PD and identify the effect of environmental factors on gut microbiota. This case–control study included 46 patients diagnosed as Parkinson’s disease (PD) and 31 healthy volunteers age and sex matched. Detailed history including age of onset, duration of disease, environmental risk factors, diet data, treatment, Unified Parkinson’s Disease Rating Scale (UPDRS), and gastrointestinal tract (GIT) domain of Non‐Motor Symptoms Scale (NMSS) were assessed. After extraction of bacterial DNA from the fecal samples, bacterial abundance was quantified by qPCR using 16S rRNA group-specific primers. Results Significant high abundance of Clostridium cluster IV, Akkermansia, Bifidobacterium, and lactic acid bacteria were found in the PD group compared with the control group (P < 0.001, 0.04, 0.02 and < 0.001, respectively), while Firmicutes were significantly less abundant in the PD group (P < 0.001) compared with the control group. The naive PD patients had significant abundance of Bifidobacterium, and lactic acid compared with control group. Interestingly, Akkermansia was more abundant in treated than untreated patients. There were significant associations between pesticide exposure and Bifidobacterium (P = 0.002), while no significant correlations between different gut microbiota and demographic, environment data, different rating scores or dominant type of PD. There was a significant negative correlation between the Bifidobacterium with the duration of illness (P = 0.012). Conclusion The present study highlighted a significant connection between PD and levels of certain types of gut microbiota, in support of a possible link between gut microbiota and a neurodegenerative cascade of PD.https://doi.org/10.1186/s41983-021-00407-zGut microbiotaParkinson’s diseaseGIT domain non‐motor symptoms
spellingShingle Eman M. Khedr
Anwar M. Ali
Enas Deaf
Hebatallah M. Hassan
Ahmed Alaa
Ayman Gamea
Gut microbiota in Parkinson’s disease patients: hospital-based study
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Gut microbiota
Parkinson’s disease
GIT domain non‐motor symptoms
title Gut microbiota in Parkinson’s disease patients: hospital-based study
title_full Gut microbiota in Parkinson’s disease patients: hospital-based study
title_fullStr Gut microbiota in Parkinson’s disease patients: hospital-based study
title_full_unstemmed Gut microbiota in Parkinson’s disease patients: hospital-based study
title_short Gut microbiota in Parkinson’s disease patients: hospital-based study
title_sort gut microbiota in parkinson s disease patients hospital based study
topic Gut microbiota
Parkinson’s disease
GIT domain non‐motor symptoms
url https://doi.org/10.1186/s41983-021-00407-z
work_keys_str_mv AT emanmkhedr gutmicrobiotainparkinsonsdiseasepatientshospitalbasedstudy
AT anwarmali gutmicrobiotainparkinsonsdiseasepatientshospitalbasedstudy
AT enasdeaf gutmicrobiotainparkinsonsdiseasepatientshospitalbasedstudy
AT hebatallahmhassan gutmicrobiotainparkinsonsdiseasepatientshospitalbasedstudy
AT ahmedalaa gutmicrobiotainparkinsonsdiseasepatientshospitalbasedstudy
AT aymangamea gutmicrobiotainparkinsonsdiseasepatientshospitalbasedstudy